Thyroid Eye Disease
Thyroid Eye Disease (TED), also known as Grave’s Ophthalmopathy, is an autoimmune disorder in which the immune system attacks healthy cells surrounding in and around the eye rather than the foreign and infectious substances. Thyroid Eye Disease is a rare disease characterized by inflammation in eyelids, tear glands, eye muscles, fatty and connective tissue present behind the eyes. When this autoimmune disease attacks the thyroid gland, the resulting disease is termed as Grave’s disease.
DelveInsight offers a brand new inclusion to its newsletter edition that centers around the Thyroid Eye Disease market. The Newsletter encompasses the complete Thyroid Eye Disease market landscape, constituting current & ongoing clinical trials, pipeline therapies, marketed and upcoming novel drugs in the Thyroid Eye Disease therapeutic area that are anticipated to transform the Thyroid Eye Disease market in the coming years. Explore more about the details of Thyroid Eye Disease epidemiological insights, recent news and happenings, mergers and collaborations, major pharmaceuticals involved, licensing deals along with events and top-level conferences expected to occur in the Thyroid Eye Disease domain.
Download our Newsletter by simply filling up the form towards the right to stay updated about all the latest developments in the Autoimmune Disorder treatment market.
Subscribe to our mailing list and learn more about our fresh offerings and services.
Know more about What's covered:
- Indication overview
- Signs, symptoms, and diagnosis
- Epidemiological trends
- Treatment approaches
- R&D in the field
- Top conferences
- News Flash
- Recent Research Activities
- Support from International organizations
- Market insights
- Market Dynamics
- Collaborations and deals in the domain